D. Shouval

D. Shouval, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation

J. Sulkes, R. Tur-kaspa, D. Shouval, 2004, Clinical transplantation.

Cell adhesion molecules and hyaluronic acid as markers of inflammation , fibrosis and response to antiviral therapy in chronic hepatitis C patients

D. Shouval, E. Granot, Y. Ashur, 2014 .

Focusing on the past, present, and future of hepatology.

S. Friedman, D. Shouval, 2014, Journal of hepatology.

Is universal vaccination against hepatitis B sufficient for control of HBV infection? Lessons from the immunization campaign in Italy.

D. Shouval, 2000, Journal of hepatology.

Expanding the donor pool for liver transplant recipients using HBsAg positive grafts.

D. Shouval, 2014, Journal of hepatology.

Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report

J. Ward, P. van Damme, D. Lavanchy, 2016, Hepatology, Medicine and Policy.

Immunization against Hepatitis A.

D. Shouval, 2019, Cold Spring Harbor perspectives in medicine.

Hepatitis A Virus

D. Shouval, 2014 .

The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation.

D. Shouval, 2014, Journal of hepatology.

Hepatitis-C-associated cryoglobulinemia after liver transplantation.

Y. Ilan, R. Safadi, R. Tur-kaspa, 1997, Transplantation proceedings.

Vaccines for prevention of viral hepatitis

C. Kessler, U. Martinowitz, C. Lee, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines – A systematic review

C. Marano, A. Stuurman, D. Shouval, 2016, Human vaccines & immunotherapeutics.

Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.

D. Shouval, M. Rowe, Y. Ashur, 1999, Vaccine.

Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.

D. Nalin, J. Davide, J. Lewis, 1993, Vaccine.

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview.

B. Wiens, D. Nalin, E. Ellerbeck, 1993, Journal of hepatology.

Relapsing Hepatitis A Review of 14 Cases and Literature Survey

M. Glikson, E. Galun, R. Tur-kaspa, 1992, Medicine.

Clofibrate does not induce peroxisomal proliferation in human hepatoma cell lines PLC/PRF/5 and SK-HEP-1.

J. Bar-Tana, D. Shouval, R. Hertz, 1987, Cancer letters.

In Vivo expression of two novel tumor‐associated antigens and their use in immunolocalization of human hepatocellular carcinoma

J. Wands, M. Ozturk, K. Endo, 1989, Hepatology.

Radioimmunolocation of hepatic and pulmonary metastasis of human colon adenocarcinoma.

K. Isselbacher, J. Wands, M. Ozturk, 1989, Gastroenterology.

Antigenic characterization of human hepatocellular carcinoma. Development of in vitro and in vivo immunoassays that use monoclonal antibodies.

K. Isselbacher, J. Wands, W. Strauss, 1985, The Journal of clinical investigation.

Premature appearance of hepatic phosphoenolpyruvate carboxykinase in fetal rats, not mediated by adenosine 3':5'-monophosphate.

D. Shouval, L. Reshef, D. Mencher, 1979, European journal of biochemistry.

Natural course of HCV viremia following liver transplantation and clinical course of reinfection.

E. Galun, D. Shouval, A. Eid, 1997, Transplantation proceedings.

A common-source outbreak of fulminant hepatitis B in a hospital.

M. Alter, S. Hadler, R. Hershow, 1989, Annals of internal medicine.

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper

M. Buti, R. Moreau, R. Jalan, 2022, Journal of Hepatology.

Evidence for Hepatitis A Virus Endemic Circulation in Israel Despite Universal Toddler Vaccination Since 1999 and Low Clinical Incidence in All Age Groups

O. Mor, E. Mendelson, R. Sheffer, 2016, The Journal of infectious diseases.

Case Report: Liver-Spleen Infarcts Following Transcatheter Chemoembolization (A Case Report and Review of the Literature on Adverse Effects)

R. Safadi, D. Shouval, Ahmed Abulfotooh Eid, 1997, Digestive Diseases and Sciences.

Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus.

Y. Ilan, D. Shouval, 1995, Journal of hepatology.

p53 expression in patients with cirrhosis with and without hepatocellular carcinoma

E. Galun, A. Rivkind, Y. Ilan, 1995, Cancer.

Changes in the Con-A-induced redistribution pattern of lymphocytes: a possible aid in the differential diagnosis between malignant lymphoma and other diseases.

A. Polliack, S. Mitrani‐Rosenbaum, A. Eldor, 1980, Blood.

Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome.

E. Fibach, D. Shouval, D. Ben‐Yehuda, 2000, Journal of hepatology.

Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines

D. W. Weiss, E. Kedar, V. Schirrmacher, 2005, Cancer Immunology, Immunotherapy.

HCC: What's the score

D. Shouval, 2002, Gut.

Immunosuppression and HBV Reactivation

O. Shibolet, D. Shouval, 2013, Seminars in Liver Disease.

Statements from the Taormina expert meeting on occult hepatitis B virus infection.

M. Buendia, J. Pawlotsky, F. Zoulim, 2008, Journal of hepatology.

Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue.

G. Dusheiko, J. Alexander, M. Kew, 1986, British Journal of Cancer.

hepatocellular carcinoma andhepatoblastoma tissue

G. Dusheiko, J. Alexander, M. Kew, 1986 .

Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.

S. Thung, D. Shafritz, M. Gerber, 1981, Cancer research.

Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.

O. Shibolet, D. Shouval, Matan J. Cohen, 2013, World journal of gastroenterology.

Development of a novel C1q immunoadsorbent for removal of circulating immunecomplexes: quantitative isolation of hepatitis B virus surface antigen and immunecomplexes.

J. Wands, S. Margel, Y. Gazitt, 1985, Immunology letters.

Correction of β-glucuronidase deficiency in mice by intrasplenic transplantation of isolated hepatocytes

E. Galun, Y. Ilan, D. Shouval, 1995 .

Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs.

E. Mitrani, Y. Ilan, D. Shouval, 2004, Journal of hepatology.

Clotting factors and hepatitis A

W. Gerlich, T. Walsh, D. Shouval, 1992, The Lancet.

The History of Hepatitis A

D. Shouval, 2020, Clinical liver disease.

Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines.

W. Gerlich, Y. Ilan, A. Panet, 1994, Vaccine.

Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity.

E. Elinav, E. Anis, O. Pappo, 2007, Journal of hepatology.

Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination.

Y. Ilan, D. Shouval, M. Mizrahi, 2008, Vaccine.

Octreotide in hepatocellular carcinoma

D. Shouval, 1998, Gut.

Production of erythropoietin by an established human renal carcinoma cell line: in vitro and in vivo studies.

D. Shouval, J. Sherwood, 1988, Advances in experimental medicine and biology.

Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice

M. Sela, J. Wands, D. Shouval, 2005, Cancer Immunology, Immunotherapy.

The hepatitis B virus–trimera mouse: A model for human HBV infection and evaluation of anti‐HBV therapeutic agents

E. Galun, J. Gillard, R. Eren, 1999, Hepatology.

Herbalife nutritional products and liver injury revisited

E. Elinav, D. Shouval, 2017 .

Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies.

S. Thung, D. Shafritz, I. Spigland, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.

B. Bloom, D. Shafritz, L. Reid, 1983, The Journal of clinical investigation.

Specific targeting of adriamycin conjugates with monoclonal antibodies to hepatoma associated antigens to intrahepatic tumors in athymic mice

M. Sela, J. Wands, D. Shouval, 1995, Hepatology.

Endotipsitis‐persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management

O. Shibolet, D. Shouval, A. Bloom, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens.

D. Shafritz, M. Kew, D. Shouval, 1981, The New England journal of medicine.

Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma.

J. Michaeli, M. Popovtzer, A. Polliack, 1993, Leukemia and Lymphoma.

Human hepatoma‐associated cell surface antigen: Identification and characterization by means of monoclonal antibodies

J. Wands, D. Shouval, R. Carlson, 1985, Hepatology.

Conservation from rat to human of cytosolic phosphoenolpyruvate carboxykinase and the control of its gene expression

N. Benvenisty, O. Meyuhas, H. Cohen, 1985, FEBS letters.

Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation

A. Nagler, E. Galun, Y. Ilan, 2001, Bone Marrow Transplantation.

Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors

A. Nagler, Y. Ilan, J. Kapelushnik, 1994, Clinical and experimental immunology.

Adoptive Transfer of Immunity to Hepatitis B Through Bone Marrow Transplantation from Immunized Donors

A. Nagler, Y. Ilan, D. Shouval, 1994 .

“Silent” presentation of veno‐occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection

D. Samuel, H. Bismuth, B. Falissard, 1999, Hepatology.

Erythropoietin-induced polycythemia in athymic mice following transplantation of a human renal carcinoma cell line.

E. Galun, M. Anton, D. Shouval, 1988, Cancer research.

Stimulation by cAMP of erythropoietin secretion by an established human renal carcinoma cell line.

D. Shouval, E. Burns, J. Sherwood, 1987, Blood.

Focus: Long-term treatment with lamivudine in HBeAg negative patients with chronic hepatitis B: to switch or not to switch?

D. Shouval, 2012, Journal of hepatology.

What is the clinical significance of the high prevalence of occult hepatitis B in US liver transplant patients with chronic hepatitis C?

D. Shouval, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.

O. Shibolet, Y. Ilan, R. Safadi, 2002, Blood.

Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon

R. Shamir, C. Hartman, D. Shouval, 2003, The Pediatric infectious disease journal.

Human Hepatoma Associated Antigens: Opportunities for Immunotherapy

D. Shouval, R. Adler, 1994 .

Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation

Amos Etzioni, D. Shouval, Y. Caraco, 1999, Hepatology.

An acupuncture-associated outbreak of hepatitis B in Jerusalem

D. Zahger, A. Leventhal, P. Slater, 1988, European Journal of Epidemiology.

Recombinant DNA and the liver: studies with albumin, alpha-fetoprotein, hepatitis B virus, and other DNA probes.

M. Zern, D. Shafritz, D. Shouval, 1982, Progress in liver diseases.

Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis: A Study of 68 Patients

Y. Ilan, D. Shouval, Y. Ashur, 2002, Journal of clinical gastroenterology.

Telaprevir for previously untreated chronic hepatitis C virus infection.

Geoffrey Dusheiko, Abdul J Sankoh, Tara L. Kieffer, 2011, The New England journal of medicine.

Telaprevir for retreatment of HCV infection.

O. Weiland, F. Nevens, S. Zeuzem, 2011, The New England journal of medicine.

The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference

M. Buti, H. Thomas, F. Roudot-thoraval, 2013, Journal of viral hepatitis.

p53 mutation in hepatocellular carcinoma after aflatoxin exposure

J. Wands, I. Sarosi, Zhao-You Tang, 1991, The Lancet.

Hepatitis C Virus Infection in Employees of a Large University Hospital in Israel

E. Galun, M. Donchin, D. Shouval, 2001, Infection Control & Hospital Epidemiology.

Papular Acrodermatitis of Childhood Associated with Hepatitis A Virus Infection

D. Shouval, E. Sagi, N. Linder, 1985, Pediatric dermatology.

Late cytomegalovirus disease following liver transplantation

D. Wolf, O. Shibolet, Y. Ilan, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences

E. Galun, S. Dagan, D. Shouval, 1997, Journal of clinical microbiology.

Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes.

J. Wands, C. Bréchot, Z. Ackerman, 1994, Journal of hepatology.

Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus

V. Zurawski, K. Isselbacher, J. Wands, 1982, Nature.

Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line

D. Shafritz, D. Shouval, Daniel Shouval, 1980, Nature.

25 – Hepatitis B Vaccines

J. Ward, A. Zanetti, D. Shouval, 2018 .

15 – Hepatitis B vaccines

J. Ward, S. Wiersma, A. Zanetti, 2013 .

Hepatitis B vaccines.

D. Shouval, 2003, Journal of hepatology.

Occupational and non-occupational hepatitis B virus infection among hospital employees in Jerusalem: a basis for immunisation strategy.

M. Donchin, D. Shouval, HealthUnit M Donchin, 1992, British journal of industrial medicine.

Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin.

D. Nalin, J. Lewis, D. Shouval, 1993, Journal of hepatology.

Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigen.

G. Amit, E. Galun, Y. Ilan, 1997, Journal of hepatology.

Conjugates between monoclonal antibodies to HBsAg and cytosine arabinoside.

J. Wands, D. Shouval, E. Hurwitz, 1986, Journal of hepatology.

Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.

V. Zurawski, K. Isselbacher, J. Wands, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Laboratory Stigmata of Connective Tissue Disorders in Asymptomatic Carriers of Hepatitis B Virus

Y. Levo, R. Tur-kaspa, M. Eliakim, 1981, The American journal of the medical sciences.

The effect of anti‐α‐fetoprotein‐adriamycin conjugate on a human hepatoma

M. Wilchek, M. Sela, E. Galun, 1990 .

Hepatotoxicity of herbal and dietary supplements: an update

F. Stickel, D. Shouval, 2015, Archives of Toxicology.

Sublines of the Burkitt line Daudi, selected on the basis of reactivity with soybean agglutinin, differ in tumorigenicity in athymic mice.

D. Shouval, H. Ben-bassat, S. Weksler-Zangen, 1988, Immunology letters.

45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(−) chronic hepatitis B patients (study ETV-027)

U. Akarca, G. Kitis, Ting Chang, 2006 .

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

Ching-Lung Lai, Anne Cross, A. Cross, 2006, The New England journal of medicine.

Natural course of de novo hepatitis B virus infection in liver transplant recipients.

Y. Ilan, D. Shouval, Y. Ashur, 1997, Transplantation proceedings.

Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation?

Y. Ilan, D. Shouval, Y. Ashur, 1997, Transplantation proceedings.

Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.

R. Shapira, R. Tur-kaspa, D. Shouval, 2002, Transplantation.

Genotypic and Phenotypic Resistance: Longitudinal and Sequential Analysis of Hepatitis B Virus Polymerase Mutations in Patients With Lamivudine Resistance After Liver Transplantation

Z. Samra, J. Sulkes, R. Tur-kaspa, 2003, American Journal of Gastroenterology.

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients.

M. Alter, R. Marinho, R. Tedder, 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Jörg Petersen, Darius Moradpour, Jean-Michel Pawlotsky, 2009, Journal of hepatology.

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.

G. Carosi, Ting Chang, D. Shouval, 2009, Journal of hepatology.

Hepatitis B vaccine failures: how do we handle them?

D. Shouval, 2020 .

Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies

D. Shouval, G. Lalazar, D. Rund, 2007, British journal of haematology.

Chronic hepatitis C virus infection with exposure to hepatitis B virus.

Y. Ilan, R. Tur-kaspa, D. Shouval, 1994, Israel journal of medical sciences.

THREE YEARS OF ENTECAVIR (ETV) RE-TREATMENT OF HBEAG(-) ETV PATIENTS WHO PREVIOUSLY DISCONTINUED ETV TREATMENT: RESULTS FROM STUDY ETV-901. 30 Oct-4 Nov, Moscone West Convention Center, San Francisco

U. Iloeje, Ting Chang, Shun‐Sheng Wu, 2009 .

Tracing hepatitis B virus to the 16th century in a Korean mummy

O. Pappo, M. Spigelman, M. Kim, 2012, Hepatology.

The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B.

D. Shouval, 2014, Journal of Hepatology.

Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.

B. Genton, M. Heim, Y. Lurie, 2006, Vaccine.

Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor.

E. Elinav, Z. Ackerman, I. Ben-Dov, 2006, Gastroenterology.

The global impact of vaccination against hepatitis B: a historical overview.

P. van Damme, A. Zanetti, D. Shouval, 2008, Vaccine.

Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries

P. van Damme, G. Ippolito, D. Lavanchy, 2008, Occupational and Environmental Medicine.

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine

H. Roggendorf, M. Roggendorf, D. Shouval, 2015, Medical Microbiology and Immunology.

Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.

F. Heinemann, H. Roggendorf, M. Roggendorf, 2014, Vaccine.

Reactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing Pre S antigens: a preliminary report

Y. Danon, D. Shouval, A. Hourvitz, 1996, Journal of viral hepatitis.

Induction of Functional Control in Chronic Hepatitis B Patients with Low Level HBsAg Using a Combination of a PreS1/S2/S HBV Vaccine (Sci-BVacTM) and a Nucleoside Analogue

G. Gerken, H. Roggendorf, M. Roggendorf, 2019, Journal of Infectious Diseases & Therapy.

Vasculitis and cryoglobulinemia associated with persisting cholestatic hepatitis A virus infection.

A. Zlotogorski, Y. Ilan, D. Shouval, 1990, The American journal of gastroenterology.

The questionable role of immunization against hepatitis B in HBV infected liver transplant patients.

D. Samuel, D. Shouval, 2005, Journal of hepatology.

The ‘ natural ’ course of hepatitis B virus infection as relevant to patients with a haematological malignancy

D. Shouval, G. Lalazar, D. Rund, 2007 .

Strategies for global prevention of hepatitis B virus infection.

P. van Damme, A. Zanetti, K. Van Herck, 2010, Advances in experimental medicine and biology.

Continued Virologic Improvement Through 96 Weeks of Entecavir Treatment in HBeAg(-) Chronic Hepatitis B Patients (Study ETV-027)

D. Dieterich, Ting Chang, D. Shouval, 2006 .

Increased prevalence of HBV envelope mutants in Taiwan: an emerging public health risk or a false alarm?

S. Locarnini, D. Shouval, 2012, Gastroenterology.

Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors

Y. Ilan, D. Shouval, R. Adler, 1993, Hepatology.

Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination.

A. Nagler, Y. Ilan, D. Shouval, 1995, Bone marrow transplantation.

Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine.

D. Shouval, M. Shapira, E. Zeira, 2001, Journal of hepatology.

Immunization against hepatitis B through adoptive transfer of immunity.

Y. Ilan, D. Shouval, 1995, Intervirology.

Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation.

Y. Ilan, R. Tur-kaspa, D. Shouval, 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The search for a new endpoint for antiviral prophylaxis in hepatitis B virus transplanted patients.

D. Shouval, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.

D. Shouval, G. Ginsberg, 1992, Journal of epidemiology and community health.

Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.

S. Berger, D. Shouval, G. Ginsberg, 1992, Bulletin of the World Health Organization.

area of intermediate endemicity . inoculation programme against hepatitis B in an Cost-benefit analysis of a nationwide neonatal

D. Shouval, G. Ginsberg, 2022 .

Hepatitis E in Israel: A nation-wide retrospective study.

D. Shouval, Eli Schwartz, N. Daudi, 2016, World journal of gastroenterology.

Commonly Found Variations/Mutations in the HBsAg of Hepatitis B Virus in the Context of Effective Immunization Programs: Questionable Clinical and Public Health Significance

S. Locarnini, D. Shouval, 2014, Journal of Virology.

One step forward in understanding the differences in antiviral response to interferon a2a and a2b in chronic hepatitis C patients with advanced fibrosis.

D. Shouval, 2012, Journal of hepatology.

Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem.

D. Engelhard, D. Shouval, S. Maayan, 1994, Addiction.

Transient Transmission of Hepatitis C Virus from Mothers to Newborns

E. Galun, M. Ketzinel-Gilad, D. Shouval, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine

H. Roggendorf, M. Roggendorf, D. Shouval, 2015, Medical Microbiology and Immunology.

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

M. Buti, P. Grossi, M. Cornberg, 2021, Journal of Hepatology.

Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection.

Z. Ackerman, D. Shouval, C. Stein-Zamir, 2012, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk

N. Linder, R. Tur-kaspa, D. Shouval, 1991, Journal of medical virology.

The case for simplifying and using absolute targets for viral hepatitis elimination goals

R. Malekzadeh, C. Richter, Chien-Jen Chen, 2020, Journal of viral hepatitis.

Acute hepatitis E virus in pregnant women in Israel and in other industrialized countries.

D. Shouval, Eli Schwartz, N. Daudi, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Immunogenicity of a Mammalian Cell-derived Recombinant Hepatitis B Vaccine Containing Pre S2 and Pre S1 Antigens: A Preliminary Report

Y. Ilan, D. Shouval, A. Hourvitz, 1994 .

IgA deficiency associated with chronic hepatitis C virus infection. A cause or an effect?

Y. Naparstek, Y. Ilan, D. Shouval, 1993, Archives of internal medicine.

Continuous production of erythropoietin by an established human renal carcinoma cell line: development of the cell line.

D. Shouval, J. Sherwood, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Caustic sclerosing cholangitis treated with orthotopic liver transplantation.

O. Pappo, R. Safadi, D. Shouval, 2002, The Israel Medical Association journal : IMAJ.

Fluidity of membrane lipids and lateral mobility of concanavalin A receptors in the cell surface of normal lymphocytes and lymphocytes from patients with malignant lymphomas and leukemias.

D. Shouval, H. Ben-bassat, M. Inbar, 1977, Cancer research.

Hepatitis A vaccines : impact of universal childhood vaccination programmes

K. Herck, D. Shouval, M. Mikhaylov, 2011 .

Air transportation of patients with end‐stage liver disease to distant liver transplantation centers

Y. Donchin, O. Shibolet, Y. Ilan, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Will transplantation of an hepatitis C-infected graft improve the outcome of liver transplantation in HCV patients?

D. Samuel, C. Féray, D. Shouval, 1999, Gastroenterology.

Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients

A. Nagler, Y. Ilan, D. Shouval, 2000, Bone Marrow Transplantation.

TT Virus Infection in Israeli Patients with Fulminant Hepatic Failure

E. Galun, Y. Ilan, R. Safadi, 2000, Vox Sanguinis.

Clotting factors and hepatitis A. Working Group on Hepatitis A and Clotting Factors.

W. Gerlich, D. Shouval, 1992, Lancet.

Lack of Evidence of Borrelia Involvement in A lzheimer's D isease

K. Reisinger, E. Walter, R. Jacobson, 2000 .

Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity.

P. Slater, D. Shouval, G. M. Ginsber, 2001, Journal of hepatology.

Hepatitis during measles in young adults: Possible role of antipyretic drugs

Z. Ackerman, M. Flugelman, M. Levy, 1989, Hepatology.

Trans‐arterial chemo‐embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database

T. Yau, R. Poon, M. Di Maio, 2014, Liver international : official journal of the International Association for the Study of the Liver.

[Circulating immune complexes in familial Mediterranean fever, systemic lupus erythematosus and HBsAg carriers].

M. Ehrenfeld, Y. Levo, M. Levy, 1979, Harefuah.

Postpartum Budd-Chiari syndrome with prolonged hypercoagulability state.

Y. Ilan, D. Shouval, R. Oren, 1990, American journal of obstetrics and gynecology.

Hepatitis A booster vaccination: is there a need?

S Iwarson, Pierre Van Damme, B. McMahon, 2003, The Lancet.

Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology

P. van Damme, S. Wiersma, K. Herck, 2008, Journal of viral hepatitis.

Prevention of Hepatitis A

D. Shouval, 2019, Viral Hepatitis in Children.

Chronic hepatitis and other liver disease

P. Van Damme, K. Herck, D. Shouval, 2009 .

Chronic active hepatitis with cholestatic features. I. A clinical and immunological study.

I. S. Levij, M. Eliakim, D. Shouval, 1979, The American journal of gastroenterology.

Active immunization against hepatitis A is now warranted in glucose-6-phosphate dehydrogenase-deficient subjects.

J. Ablin, Z. Ackerman, D. Shouval, 1996, The American journal of gastroenterology.

Primary biliary cirrhosis in Israel.

Y. Ilan, D. Shouval, 1992, Israel journal of medical sciences.

Hepatitis A Prophylaxis

D. Shouval, Dr Ruth Adler, 1996, Clinical Immunotherapeutics.

Measles: Clinical and Laboratory Observations in Young Adults During an Epidemic

D. Shouval, E. Ackerman, ZVI ACKERMAN, 1988, Southern medical journal.

Hepatitis A and B vaccination and public health

P. van Damme, B. Bell, S. Wiersma, 2007, Journal of viral hepatitis.

Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis

Y. Ilan, D. Shouval, Y. Ashur, 2002 .

A finger-stick assay for determination of immunity to hepatitis A: a preliminary report.

D. Shouval, R. Adler, 1993, Journal of hepatology.

Liver transplantation across the ABO barrier: the role of plasmapheresis.

E. Galun, G. Zamir, D. Shouval, 1998, Transplantation proceedings.

Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized rats.

R. Shemesh, E. Mitrani, Y. Ilan, 2003, Journal of hepatology.

REDUCED INCIDENCE OF HYPERURICEMIA, GOUT, AND RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION IN COMPARISON TO HEART TRANSPLANTATION: A LONG-TERM FOLLOW-UP STUDY

E. Elinav, O. Shibolet, Y. Ilan, 2004, Transplantation.

Detection of hepatitis a virus rna in serum from patients with acute hepatitis

R. Tur-kaspa, D. Shouval, R. Oren, 1989, Journal of medical virology.

Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.

D. Greenberg, P. van Damme, K. Reisinger, 1999, The Journal of infectious diseases.

Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries.

F. Tacke, V. de Lédinghen, M. Buti, 2023, Journal of hepatology.

Hepatocellular carcinoma.

W. Meyers, J. Llovet, E. Akriviadis, 1998, The British journal of surgery.

Late cytomegalovirus infection occurring two or more years following liver transplantation: a report of seven cases and review of the literature.

D. Wolf, O. Shibolet, Y. Ilan, 2003, Transplantation Proceedings.

Hyper-IL-6 gene therapy reverses fulminant hepatic failure.

S. Rose-John, E. Galun, O. Pappo, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Asian Pacific Association for Study of the Liver (APASL)

M. Alter, M. Hashizume, M. Manns, 2003 .

Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus.

E. Galun, M. Ligumsky, Y. Ilan, 1996, Scandinavian journal of gastroenterology.

Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.

K. Isselbacher, M. Sela, J. Wands, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Liver failure and the sea-blue histiocyte/adult Niemann-Pick disease. Case report and review of the literature.

C. Putterman, D. Shouval, J. Zelingher, 1992, Journal of clinical gastroenterology.

Embolization of hepatocellular carcinoma with drug-eluting beads: new insight into the biologic effects of tumor ablation.

D. Shouval, 2011, Journal of hepatology.

Hepatitis C-associated cryoglobulinemia presenting with pericardial effusion.

Y. Ilan, D. Shouval, Y. Ashur, 1997, The American journal of gastroenterology.

[An outbreak of hepatitis B associated with acupuncture].

D. Zahger, P. Slater, D. Shouval, 1989, Harefuah.

Type B and non-B viral hepatitis in Jerusalem.

M. Eliakim, D. Shouval, S. Sandler, 1976, Bulletin of the World Health Organization.

Mononeuritis multiplex: a rare complication of acute hepatitis A.

T. Ben-Hur, R. Safadi, D. Shouval, 2008, Liver.

TypeBandnon-Bviral hepatitis inJerusalem*

M. Eliakim, D. Shouval, M. Marcus, 1976 .

Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial.

B. Wiens, D. Nalin, R. Sitrin, 1993, Journal of hepatology.

Rapid seroprotection against hepatitis B following the ® rst dose of a PreS 1 / PreS 2 / S vaccine

D. Shouval, M. Shapira, E. Zeira, 2000 .

Cost-benefit analysis ofanationwide inoculation programme against viral hepatitis B inanareaofintermediate endemicity

S. Berger, D. Shouval, G. Ginsberg, 1992 .

TEMPORARY REMOVAL: Hepatitis A and E - differences and commonalities.

D. Moradpour, D. Shouval, N. Gotlieb, 2020, Journal of Hepatology.

Chapter 29 – Hepatitis A

D. Shouval, 2012 .

Evidence for Hepatitis A Virus Endemic Circulation in Israel Despite Universal Toddler Vaccination Since 1999 and Low Clinical Incidence in All Age Groups.

O. Mor, E. Mendelson, R. Sheffer, 2016, Journal of Infectious Diseases.

Transient cortical blindness in hepatic encephalopathy.

Y. Naparstek, M. Eliakim, D. Shouval, 1979, Israel journal of medical sciences.

Improvement of immune-complex nephritis associated with hepatitis B surface antigen excess.

J. Michaeli, E. Raz, Y. Gazitt, 1989, American journal of nephrology.

Expanding the donor pool for liver transplant recipients using HBsAg positive grafts.

D. Shouval, 2014, Journal of hepatology.

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.

Jisoo A. Kwon, R. Malekzadeh, F. Tacke, 2023, The lancet. Gastroenterology & hepatology.

Hepatitis D double reﬂex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

F. Tacke, M. Buti, J. Lazarus, 2023 .

Hepatitis A virus and polymerase chain reaction amplification: methodology and results.

B. Robertson, D. Friedberg, D. Shouval, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Fatal relapsing viral hepatitis A infection during pregnancy.

D. Shouval, A. Furst, E. Horenstein, 1988, Israel journal of medical sciences.

Tracing hepatitis B virus to the 16th century in a Korean mummy

O. Pappo, M. Spigelman, M. Kim, 2012, Hepatology.

Hepatotoxicity of herbal and dietary supplements: an update

F. Stickel, D. Shouval, Daniel Shouval, 2015, Archives of Toxicology.

Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors

Y. Ilan, D. Shouval, R. Adler, 1993, Hepatology.

Adoptive transfer of immunity to hepatitis B : development of the concept and evolution of the research project for targeted immunotherapy against hepatic cells which express a viral antigen

Y. Ilan, D. Shouval, 1995 .

Adoptive immune transfer as a therapeutic approach for persistent hepatitis B virus infection

D. Shouval, 2003 .

Focus: quantitative HBsAg measurement as a new surrogate marker for assessment of hepatic fibrosis in HBeAg+ chronic hepatitis B.

D. Shouval, 2013, Journal of hepatology.

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.

G. Carosi, Ting Chang, D. Shouval, 2009, Journal of hepatology.

Focus. What is the significance of hepatitis E as a public health threat in the industrialized countries? Hepatitis E virus infection in Italy.

D. Shouval, 2011, Journal of hepatology.

FOCUS

D. Shouval, 1985, Les Tribunes de la santé.